Trademark Search in Canada

FINZALA

View On IC.GC.CA

REGISTERED

on 21 Mar 2024

Last Applicant/ Owned by

TEVA PHARMACEUTICALS USA INC.

400 Interpace Parkway, Building AParsippany, NJ 07054

Serial Number

2145729 filed on 8^th Nov 2021

Registration Number

TMA1226031 registered on 21^st Mar 2024

Registration expiry Date

21^st Mar 2034

Correspondent Address

OSLER, HOSKIN & HARCOURT LLP

Suite 320, World Exchange Plaza100 Queen StreetOttawa,

ONTARIO

K1P1J9

FINZALA

Trademark usage description

pharmaceutical preparations for the treatment of alimentary, anti-parasitic, autoimmune, blood-related, cancer, cardiovascular, central nervous system Read More

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of alimentary, anti-parasitic, autoimmune, blood-related, cancer, cardiovascular, central nervous system, dermatological, endocrine, gastrointestinal, immunological, infectious, inflammatory, menopausal, musculo-skeletal, neurological, opthalmological, pain, renal, metabolic, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for use in hematology, namely for the treatment of blood disorders.

Classification kind code

Mark Details

Serial Number

2145729

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 27 on 6^th Dec 2023	Approval Notice Sent
Submitted for opposition 26 on 6^th Dec 2023	Approved
Submitted for opposition 23 on 30^th Nov 2023	Default Removed
Submitted for opposition 14 on 21^st Nov 2023	Default Notice Sent
Submitted for opposition 22 on 24^th Apr 2023	Search Recorded
Submitted for opposition 20 on 24^th Apr 2023	Examiner's First Report
Submitted for opposition 287 on 12^th Jul 2022	Pre-Assessment Letter Sent
Submitted for opposition 30 on 8^th Nov 2021	Filed
Submitted for opposition 1 on 8^th Nov 2021	Created
Submitted for opposition 31 on 8^th Nov 2021	Formalized